14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $11.01 $14.21 Friday, 3rd May 2024 IOVA stock ended at $13.63. This is 5.82% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.36% from a day low at $13.30 to a day high of $13.88.
90 days $7.62 $18.33
52 weeks $3.21 $18.33

Historical Iovance Biotherapeutics, Inc. prices

Date Open High Low Close Volume
Dec 08, 2023 $6.67 $6.83 $6.33 $6.40 7 165 773
Dec 07, 2023 $6.36 $6.75 $6.28 $6.73 5 811 674
Dec 06, 2023 $6.32 $6.62 $6.24 $6.38 4 935 629
Dec 05, 2023 $6.58 $6.69 $6.25 $6.27 6 187 998
Dec 04, 2023 $6.27 $6.65 $6.20 $6.64 5 927 371
Dec 01, 2023 $6.05 $6.28 $5.76 $6.26 6 369 481
Nov 30, 2023 $5.91 $6.58 $5.84 $6.07 11 596 386
Nov 29, 2023 $5.61 $5.92 $5.61 $5.68 4 838 860
Nov 28, 2023 $5.48 $5.77 $5.41 $5.57 4 683 675
Nov 27, 2023 $5.82 $5.87 $5.43 $5.53 6 049 621
Nov 24, 2023 $5.48 $5.95 $5.48 $5.79 4 876 396
Nov 22, 2023 $5.34 $5.51 $5.24 $5.40 4 612 426
Nov 21, 2023 $5.45 $5.49 $5.14 $5.17 7 027 216
Nov 20, 2023 $5.54 $5.83 $5.33 $5.49 21 688 800
Nov 17, 2023 $4.46 $5.08 $4.44 $5.05 13 553 389
Nov 16, 2023 $4.73 $4.75 $4.33 $4.40 5 243 676
Nov 15, 2023 $4.73 $4.97 $4.66 $4.75 5 378 900
Nov 14, 2023 $4.29 $4.73 $4.29 $4.71 7 331 105
Nov 13, 2023 $3.90 $4.04 $3.80 $4.03 2 230 395
Nov 10, 2023 $3.98 $4.02 $3.76 $3.97 4 139 368
Nov 09, 2023 $4.30 $4.41 $3.91 $3.95 6 918 015
Nov 08, 2023 $4.49 $4.70 $4.15 $4.17 11 543 838
Nov 07, 2023 $4.31 $4.37 $4.10 $4.32 6 948 173
Nov 06, 2023 $4.34 $4.39 $3.98 $4.32 5 012 152
Nov 03, 2023 $3.98 $4.33 $3.98 $4.21 8 484 659
Click to get the best stock tips daily for free!

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics. Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers... IOVA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT